1. Xiong, C., Huang, L., Kou, H., Wang, C., Zeng, X., Sun, H., Liu, S., Wu, B., Li, J., Wang, X.,
Wang, Z., & Chen, L. (2022). Identification of novel HLA-A*11:01-restricted HPV16 E6/E7 epitopes and
T-cell receptors for HPV-related cancer immunotherapy. Journal for ImmunoTherapy of Cancer, 10(9),
e004790.
2. Wang, Z., Liu, Y., Peng, L., Till, B., Liao, Y., Yuan, S., Yan, X., Chen, L., Fu, Q., & Qin, Z. (2022).
Role of fibrosarcoma-induced CD11b+ myeloid cells and tumor necrosis factor- α in B cell responses.
Oncogene, 41(10), 1434–1444.
3. Wang, C., Xiong, C., Hsu, Y., Wang, X., Chen, L. (2020). Human leukocyte antigen (HLA) and
cancer immunotherapy: HLA-dependent and -independent adoptive immunotherapies. Annals of Blood,
5(4), 14–14.
4. Li, Q., Dai, C., Xue, R., Wang, P., Chen, L., Han, Y., Erben, U., & Qin, Z. (2018). S100A4 protects
myeloid-derived suppressor cells from intrinsic apoptosis via TLR4-ERK1/2 signaling. Frontiers in
Immunology, 9(MAR), 1–14.
5. Chen, L., Li, J. , Wang, F., Dai, C., Wu, F., Liu, X., Li, T., Glauben, R., Zhang, Y., Nie, G., He, Y.,
& Qin, Z. (2016). Tie2 expression on macrophages is required for blood vessel reconstruction and tumor
relapse after chemotherapy. Cancer Research, 76(23), 6828–6838.
6. Chen, L., Li, J., Zhang, J., Dai, C., Liu, X., Wang, J., Gao, Z., Guo, H., Wang, R., Lu, S., Wang, F.,
Zhang, H., Chen, H., Fan, X., Wang, S., & Qin, Z. (2015). S100A4 promotes liver fibrosis via activation of
hepatic stellate cells. Journal of Hepatology, 62(1), 156–164.
代表性成果: